US Stock MarketDetailed Quotes
AFIB Acutus Medical
- 0.154
- -0.005-3.37%
15min DelayClose Nov 4 16:00 ET
4.58MMarket Cap-90P/E (TTM)
0.160High0.139Low80.54KVolume0.150Open0.159Pre Close12.26KTurnover0.28%Turnover RatioLossP/E (Static)29.78MShares0.43052wk High-0.95P/B4.46MFloat Cap0.02552wk Low--Dividend TTM29.02MShs Float38.990Historical High--Div YieldTTM13.21%Amplitude0.025Historical Low0.152Avg Price1Lot Size
Acutus Medical Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 172.41%4.13M | 191.87%3.63M | 136.36%7.16M | 10.01%-7.53M | 43.74%5.24M | -62.83%1.52M | -66.26%1.24M | -82.44%3.03M | -291.88%-8.37M | -20.80%3.64M |
| Operating revenue | 172.41%4.13M | 191.87%3.63M | 136.36%7.16M | 10.01%-7.53M | 43.74%5.24M | -62.83%1.52M | -66.26%1.24M | -82.44%3.03M | -291.88%-8.37M | -20.80%3.64M |
| Cost of revenue | 76.89%4.47M | 73.14%3.66M | 108.48%10.3M | 29.50%-13.15M | 23.65%8.6M | -73.94%2.53M | -69.59%2.11M | -84.99%4.94M | -287.62%-18.65M | -18.60%6.95M |
| Gross profit | 66.11%-343K | 96.55%-30K | -64.24%-3.14M | -45.38%5.61M | -1.51%-3.36M | 82.00%-1.01M | 73.34%-869K | 87.80%-1.91M | 284.29%10.28M | 16.02%-3.31M |
| Operating expense | -46.99%2.23M | -38.32%3.34M | -25.11%17.55M | 27.86%-26.44M | -21.75%12.23M | -80.99%4.2M | -75.84%5.41M | -76.62%23.43M | -248.38%-36.66M | -37.76%15.63M |
| Selling and administrative expenses | -32.16%2.23M | -25.38%3.34M | -30.76%14.07M | 31.73%-12.21M | -23.22%7.43M | -76.81%3.28M | -68.91%4.47M | -68.02%20.32M | -212.78%-17.89M | -38.76%9.68M |
| Research and development costs | --0 | --0 | 11.67%3.48M | 24.17%-14.23M | -19.36%4.8M | -88.44%917K | -88.28%938K | -91.50%3.12M | -312.29%-18.77M | -36.06%5.95M |
| Operating profit | 50.70%-2.57M | 46.38%-3.37M | 18.38%-20.69M | -31.70%32.06M | 17.68%-15.58M | 81.19%-5.21M | 75.52%-6.28M | 78.13%-25.34M | 255.00%46.94M | 34.81%-18.93M |
| Net non-operating interest income expense | -128.20%-1.3M | -163.66%-1.2M | 28.36%-3.07M | -54.65%-1.18M | 0.69%-862K | 54.79%-571K | 67.27%-454K | 23.02%-4.28M | 44.06%-763K | 38.96%-868K |
| Non-operating interest income | -74.88%207K | -67.06%281K | 198.16%2.59M | -36.63%365K | 126.97%547K | 2,951.85%824K | 3,454.17%853K | 648.28%868K | 1,957.14%576K | 1,168.42%241K |
| Non-operating interest expense | 8.24%1.51M | 13.08%1.48M | 9.83%5.66M | 15.38%1.55M | 27.05%1.41M | 8.14%1.4M | -7.37%1.31M | -9.30%5.15M | -3.81%1.34M | -23.04%1.11M |
| Other net income (expense) | 127.12%3.51M | 2.28%2.51M | -79.66%11.89M | -86.40%5.09M | 625.44%3.28M | -95.54%1.55M | 118.90%2.45M | 1,460.92%58.47M | 9,690.31%37.4M | -132.00%-625K |
| Gain on sale of security | 193.38%564K | -119.57%-283K | 8,800.00%2.94M | 267.51%1.46M | -29.65%636K | ---604K | --1.45M | --33K | ---871K | --904K |
| Special income (charges) | 33.50%2.87M | 177.26%2.79M | -84.67%8.96M | -90.52%3.63M | 273.19%2.65M | -93.80%2.15M | 107.76%1.01M | 1,460.04%58.44M | 9,918.32%38.27M | -178.29%-1.53M |
| -Less：Restructuring and merger&acquisition | --0 | --0 | -88.32%123K | 80.04%-475K | --0 | -108.12%-77K | -79.08%200K | 128.11%1.05M | -523.04%-2.38M | 178.29%1.53M |
| -Less:Impairment of capital assets | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --12.03M | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7.95M | --0 | ---- |
| -Gain on sale of business | 38.47%2.87M | 131.32%2.79M | -88.57%9.08M | -91.21%3.15M | --2.65M | -95.24%2.07M | --1.21M | --79.47M | --35.89M | --0 |
| Other non- operating income (expenses) | --76K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 91.45%-362K | 51.99%-2.06M | -141.11%-11.86M | -56.97%35.97M | 35.56%-13.16M | -174.06%-4.24M | 89.30%-4.28M | 124.51%28.85M | 367.31%83.57M | 28.36%-20.43M |
| Income tax | 0 | 320.00%63K | -180.00%-12K | 75K | 0 | 15K | 15K | 0 | ||
| Net income | 95.02%-914K | 90.07%-1.62M | -106.14%-81.66M | -323.49%-33.77M | 35.19%-13.24M | -420.85%-18.35M | 59.23%-16.32M | 66.34%-39.62M | 148.32%15.11M | 28.36%-20.43M |
| Net income continuous Operations | 91.45%-362K | 51.99%-2.06M | -141.34%-11.92M | -56.94%35.98M | 35.19%-13.24M | -174.06%-4.24M | 89.30%-4.28M | 124.50%28.83M | 367.26%83.56M | 28.36%-20.43M |
| Net income discontinuous operations | 96.09%-552K | 103.61%435K | -1.89%-69.74M | ---- | ---- | ---14.11M | ---12.04M | ---68.45M | ---- | ---- |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 95.02%-914K | 90.07%-1.62M | -106.14%-81.66M | -323.49%-33.77M | 35.19%-13.24M | -420.85%-18.35M | 59.23%-16.32M | 66.34%-39.62M | 148.32%15.11M | 28.36%-20.43M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 95.02%-914K | 90.07%-1.62M | -106.14%-81.66M | -323.49%-33.77M | 35.19%-13.24M | -420.85%-18.35M | 59.23%-16.32M | 66.34%-39.62M | 148.32%15.11M | 28.36%-20.43M |
| Basic earnings per share | 95.24%-0.03 | 89.47%-0.06 | -100.71%-2.81 | -318.87%-1.16 | 37.50%-0.45 | -493.75%-0.63 | 59.86%-0.57 | 65.94%-1.4 | 147.32%0.53 | 23.40%-0.72 |
| Diluted earnings per share | 95.24%-0.03 | 89.47%-0.06 | -100.71%-2.81 | -382.93%-1.16 | 37.50%-0.45 | -493.75%-0.63 | 59.86%-0.57 | 65.94%-1.4 | 136.61%0.41 | 23.40%-0.72 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
